U-Neuron Biomedical Inc (TPEX:6973)
Taiwan · Delayed Price · Currency is TWD 32.90
-0.75 (-2.23%)
May 29, 2026, 1:22 PM CST
U-Neuron Biomedical Market Cap
U-Neuron Biomedical has a market cap or net worth of 1 billion as of May 29, 2026. Its market cap has decreased by -14.14% in one year.
Market Cap
1.00B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
32.90
Market Cap Chart
Since July 20, 2023, U-Neuron Biomedical's market cap has decreased from 1.36B to 1.00B, a decrease of -26.09%. That is a compound annual growth rate of -10.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 1.00B | -10.29% |
| Dec 31, 2025 | 1.12B | -9.44% |
| Dec 31, 2024 | 1.24B | -30.25% |
| Dec 29, 2023 | 1.77B | 30.43% |
| Jul 20, 2023 | 1.36B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BiOptic | 1.15B |
| Level Biotechnology | 1.08B |
| Lukas Biomedical | 1.04B |
| Holy Stone Healthcare | 1.04B |
| GeneReach Biotechnology | 1.02B |
| LabTurbo Biotech | 1.01B |
| TCI GENE | 976.32M |
| Taiwan Advance Bio-Pharmaceutical | 922.50M |